Showing 5521-5530 of 8159 results for "".
- Suneva Medical Announces Expansion Of Its ReGenica Distribution Partnership With Obagi Medical Productshttps://practicaldermatology.com/news/20131101-suneva_medical_announces_expansion_of_its_regenica_distribution_partnership_with_obagi_medical_product/2459424/Suneva Medical, Inc., recently announced plans to expand its existing partnership with Obagi Medical Products, Inc. Suneva Medical distributes, and is the exclusive licensee for, the full line of ReGenica skincare produ
- Onset Dermatologics Acquires Worldwide Rights to Clindagel from Galderma Laboratorieshttps://practicaldermatology.com/news/20131031-onset_dermatologics_acquires_worldwide_rights_to_clindagel_from_galderma_laboratories/2459425/Onset Dermatologics, LLC recently announced the acquisition of Clindagel (clindamycin phosphate gel 1%), a prescription topical antibiotic for the treatment of acne, from Galderma Laboratories. Clindagel is the only FDA-approved topical form
- New Stelara Data Show Inhibition Of Joint Destruction In Psoriatic Arthritis Patientshttps://practicaldermatology.com/news/20131029-new_stelara_data_show_inhibition_of_joint_destruction_in_psoriatic_arthritis_patients/2459427/New findings from two integrated Phase III Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with ustekinumab (Stelara) resulted in
- Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticumhttps://practicaldermatology.com/news/20131024-auxilium_pharmaceuticals_inc_announces_first_patient_dosed_in_phase_2a_cellulite_study_of_collegenase_clostridium_histolyticum/2459430/Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully-integrated specialty biopharmaceutical company, today announced the first patient dosed in its Phase 2a study of collagenase clostridium histolyticum (or "CCH") for the treatment of edematous fibrosclerotic panniculopathy ("EFP"), commonly known
- Juvéderm Voluma XC Approved in UShttps://practicaldermatology.com/news/20131023-juvderm_voluma_xc_approved_in_us/2459431/The FDA has approved Juvéderm Voluma XC (Allergan), the first injectable filler approved to temporarily correct age-related volume loss in the cheek area in adults over the age of 21. The approval is based on a pivotal clinical trial in the US and Canada demonstrating that Juvéderm Vol
- Ellzey Coding Solutions Introduces ICD-10 for Dermatology Manualhttps://practicaldermatology.com/news/20131010-ellzey_coding_solutions_introduces_icd-10_for_dermatology_manual/2459440/Ellzey Coding Solutions, Inc., recently released an ICD-10 coding manual specifically for dermatologists. The 2014 ICD-10 for Dermatology program is a tool that can be used to prepare dermatologists and staff with what they need to know about the ICD-10-CM diagnosis coding syste
- Valeant to Help Raise Awareness of Domestic Violencehttps://practicaldermatology.com/news/20131002-valeant_to_help_raise_awareness_of_domestic_violence/2459444/Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) is partnering with the National Coalition Against Domestic Violence (NCADV) to help raise awareness of domestic violence. As p
- MELA Sciences Appoints Dr. Darrell Rigel as Chief Medical Advisor to Its Board of Directorshttps://practicaldermatology.com/news/20131001-mela_sciences_appoints_dr_darrell_rigel_as_chief_medical_advisor_to_its_board_of_directors/2459445/MELA Sciences, Inc., announced that Darrell S. Rigel, MD, MS, Clinical Professor of Dermatology at New York University, Langone Medical Center, has been appointed Chief Medical Advisor to the Company's Board of Directors. Dr. Rigel is a Clinical Profes
- Dermatologist Launches Sunscreen with Zinc, Anti-cancer Agentshttps://practicaldermatology.com/news/20130926-dermatologist_launches_sunscreen_with_zinc_anti-cancer_agents/2459449/Rejuve MD is an anti-aging sunblock that includes only Zinc Oxide as the sunblock without the need to use chemical sunscreens. Rejuve MD sunblock is also unique in that it not only prevents UV radiation sun damage from both UVB but also UVA light and it also has anti-aging and anti-cancer forming na
- Patient Savings Program Available for Mylan's Doxycycline Hyclatehttps://practicaldermatology.com/news/20130925-patient_savings_program_available_for_mylans_doxycycline_hyclate/2459450/Patients who are prescribed Mylan's bioequivalent alternative to Doryx (doxycycline hyclate delayed-release tablets) USP for severe acne may be eligible for an instant savings program. Patients who take their prescriptions to participating pharmacies will receive an automatic co-pay reduction at the